The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections: An Update

Amos Adler, David E. Katz, Dror Marchaim*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Antimicrobial resistance is a common iatrogenic complication of modern life and medical care. One of the most demonstrative examples is the exponential increase in the incidence of extended-spectrum β-lactamases (ESBLs) production among Enterobacteriaceae, that is, the most common human pathogens outside of the hospital setting. Infections resulting from ESBL-producing bacteria are associated with devastating outcomes, now affecting even previously healthy individuals. This poses an enormous burden and threat to public health. This article aims to narrate the evolving epidemiology of ESBL infections and highlights current challenges in terms of management and prevention of these common infections.

Original languageEnglish
Pages (from-to)677-708
Number of pages32
JournalInfectious Disease Clinics of North America
Volume34
Issue number4
DOIs
StatePublished - Dec 2020

Funding

FundersFunder number
Merck

    Keywords

    • Escherichia coli
    • Gram-negative
    • Klebsiella pneumoniae
    • MDRO
    • Proteus mirabilis

    Fingerprint

    Dive into the research topics of 'The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections: An Update'. Together they form a unique fingerprint.

    Cite this